NOT KNOWN FACTUAL STATEMENTS ABOUT WHAT ARE THE BEST NEUROPROTECTIVE DRUGS?

Depending on the subgroup Assessment, we uncovered that there was substantial heterogeneity with regards to mortality, favorable outcomes, and the overall cure efficient level. Relating to mortality, The rationale for heterogeneity to the subgroup of edaravone dexborneol and EDV was mainly attributed to differences in drug dosage. Pertaining to fav